☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Marketing authorization
Decoding Approval: Moitreyee Chatterjee-Kishore from Astellas in an Exclusive Conversation with PharmaShots
September 26, 2024
Enzene Receives Marketing Authorization for Romiplostim (biosimilar) in India
August 20, 2021
Biogen's Tysabri (natalizumab- SC) Receives EC's Marketing Authorization to Treat Relapsing-Remitting Multiple Sclerosis
April 8, 2021
Bayer's Vitrakvi Receives MHLW's Approval for the Treatment of NTRK Fusion-Positive Advanced or Recurrent Solid Tumors
March 24, 2021
Enzene Receives Marketing Authorization for Teriparatide (biosimilar) in India
February 5, 2021
Celltrion Receives Health Canada's Approval for Remsima SC (biosimilar- infliximab) for Rheumatoid Arthritis
February 2, 2021
Load more...
Back to Home
Modal title
×
Modal body text goes here.